Work as Country Brand Manager at Pfizer India
Pfizer India Inflammation and Immunology comprises of several industry leading assets in the field of Rheumatology. Additionally, we also have a robust pipeline upcoming in the Dermatology & Gastroenterology Portfolio, starting with the launch of a breakthrough molecule for Atopic Dermititis followed by advanced molecules. The upcoming molecules enable significant therapeutic benefits to patients and will offer Pfizer's innovation for Atopic Dermatitis Patients as an alternative to Topical Steroids and Calcineurin Inhibitors.